Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T21:43:06.994Z.
Consensus retrieved: 2026-10-06T16:40:19.175Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T21:43:06.994Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d1c9d1ae32ec6dd6af333f7eb1423604a85a264941186084cc2bd56372a90b7e
Forward PE Ratio (N/A) = Dated Quote Price ($2.97) / Consensus Forward EPS ($-0.79)
FORWARD PE RATIO
N/A
Sensus Healthcare, Inc.
Market Cap
$48.89M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | $48.89M | N/A |
| TELA Bio, Inc. (TELA)vs › | $48.77M | N/A |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | N/A |
| Apollomics, Inc. (APLM)vs › | $48.53M | N/A |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.25M | N/A |
| Clene Inc. (CLNN)vs › | $49.45M | N/A |
| INmune Bio, Inc. (INMB)vs › | $49.71M | N/A |
| Lite Strategy, Inc. (LITS)vs › | $47.98M | N/A |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | N/A |
| biote Corp. (BTMD)vs › | $50.28M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $2.97, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-0.79 | $-0.89 – $-0.70 | 2 | n/m |
| 2027-12-31 | $-0.11 | $-0.20 – $-0.04 | 3 | n/m |
| 2028-12-31 | $0.05 | $0.04 – $0.06 | 2 | 59.4x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
